Announcement on Convening the 2024 Semi-Annual Performance Briefing
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
Announcement on Convening the 2024 Semi-Annual Performance Briefing
Filed with SSE · · 2 pages · Chinese
Release
Zhejiang Medicine Co., Ltd. on 6ix
Earlier from Zhejiang Medicine
- Semi-annual Report in 2024
- Announcement on Obtaining the Drug Registration Certificate of Daptomycin for Injection
- Announcement on Completing Industrial and Commercial Change Registration and Renewing Business License
- Announcement on Implementation of Dividend Distribution for 2023
- Announcement on Implementation of Repurchasing and Canceling Registration of Some Restricted Shares
Later from Zhejiang Medicine
- Announcement on Company's Drug Metaraminol Bitartrate Injection Passing Consistency Evaluation of Generic Drug
- Report for Q3 2024
- Indicative Announcement on Changes in Equity Structure of Controlling Shareholder and Actual Controller
- Announcement on "Corporate Value and Return Enhancement" Action Plan
- Announcement on Completion of Industrial and Commercial Registration for Changes in Equity Structure of Controlling Shareholder and Change of Actual Controller
Follow Zhejiang Medicine into a list and get an email when it puts out news.
Follow Zhejiang Medicine